Roche in the news

Catch up on the latest news, innovation and thought leadership from Roche Diagnostics.

Select Science - September 1, 2026

How automated mass spectrometry is expanding clinical lab capacity

Discover how clinical labs are leveraging fully automated mass spectrometry systems to eliminate complex workflows, drastically reduce hands-on time and unlock new testing capacity.

Automated LC-MS/MS brings clinical mass spectrometry closer to routine testing

Learn how fully automated LC-MS/MS is eliminating complex workflows and transforming core lab capabilities.

Blood-Based Biomarkers Are Transforming the Diagnosis of Alzheimer’s Disease

Discover how FDA-cleared blood-based biomarkers are driving a pivotal shift in Alzheimer's testing by eliminating care delays and streamlining evaluations across primary and specialty care.

A Turning Point for Clinical Mass Spec?

Learn how fully automated solutions are helping to overcome traditional barriers, bringing high-specificity hormone testing into routine clinical laboratories.

Building Resilient Clinical Labs Amidst Workforce Shortages

Outlining how breakthrough automation and decoupled system designs are protecting lab capacity and preventing burnout.

‘Moderate Complexity’ Mass Spectrometry Arrives in Clinical Labs

A blueprint for operational survival, highlighting how strategic automation and decoupled instrument designs can rescue staff capacity and prevent burnout.

Past Coverage

2025

Clinical Lab Products Magazine

December 25, 2025

Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend

In this article from Clinical Lab Products, Dr. Carolyn Kay of Roche Diagnostics explores why millennials are delaying cervical-cancer screenings and how innovations like HPV self-collection can help close the gap. She highlights that making screening more convenient and accessible is critical to reversing declining rates and achieving global elimination goals.

CNN

October 13, 2025

FDA clears blood test to help rule out Alzheimer’s disease in people showing symptoms

CNN covers groundbreaking news about the Elecsys® pTau181 blood test, the first FDA-cleared Alzheimer’s diagnostic for primary care. Learn how this new biomarker test is poised to transform early diagnosis and patient-care pathways for amyloid pathology.

Becker Hospital Review

September 23, 2025

Pathology labs are redefining ROI for digital pathology

This article features insights from industry leaders Sam Terese (former CEO/President of Alverno Laboratories) and Dr. Meiklejohn McKenzie (Community Pathology Laboratory). They explore how pathology labs are redefining the ROI of digital pathology, emphasizing its value in improving accuracy, boosting pathologist morale, and addressing the workforce shortage.

Clinical Lab Products Magazine

September 18, 2025

Why One Pathologist Calls for a ‘Patient Behind Every Sample’ Mindset

In this article, Denise Heaney, PhD, emphasizes the crucial need for a "patient behind every sample" mindset in laboratory culture, noting that diagnostic testing should serve as a bridge to better health and equitable care. She discusses how advances like multiplex assays and digital health tools are reshaping infectious disease testing to enhance accessibility and efficiency.

MedCity News

July 17, 2025

Two Imperatives for the Future of Diagnostics: Adaptability and Digitalization to Unlock the Potential of AI

In this story, Antonio Vergara, Senior Vice President, Core Lab and Near Patient Care, explores two key trends shaping the future of diagnostics: adaptability and digitalization. He discusses how these trends, combined with AI, can improve patient access to care while increasing lab efficiency.

Clinical Lab Products Magazine

June 18, 2025

Should labs add Lp(a) testing to their menus?

Alexander Fohl, scientific partner for cardiometabolism, explores why labs should consider adding Lp(a) testing to their menus. Discover how this crucial biomarker improves cardiovascular risk assessment, its clinical utility, and the benefits of standardization for broader adoption. Learn more about elevating patient care.

American Journal of Clinical Pathology

June 10, 2025

Roche Digital Pathology Dx whole slide imaging system is comparable to traditional microscopy for primary diagnosis in surgical pathology

A new study in AJCP highlights the robust evaluation of the Roche Digital Pathology Dx system. This research demonstrates its strong precision and accuracy, proving comparability to traditional microscopy for primary diagnosis in surgical pathology.

Neurology Today

March 25, 2025

Streamlining patient pathways in Alzheimer's disease with emerging biomarkers

Dr. Maria-Magdalena Patru highlights how blood-based biomarkers are transforming early Alzheimer’s detection – offering scalable, minimally invasive testing to support timely diagnoses and improve patient care pathways.

Clinical Lab Products Magazine

March 25, 2025

COVID next: Charting an evolving industry

Clinical diagnostics is evolving rapidly in the wake of COVID-19. Industry leaders highlight trends like AI, automation and at-home testing that show how clinical diagnostics are evolving after COVID-19’s pandemic phase.

Clinical Lab Products Magazine

March 24, 2025

The COVID-19 pandemic: Five years on

Nathan Patton, vice president of Near Patient Care marketing, joins industry experts to reflect on COVID-19’s impact – from early challenges to the rise of point-of-care testing and stronger public health preparedness.

Infectious Diseases Today - Contagion Live

March 20, 2025

The COVID-19 pandemic: Significance of screening and industry's response

The pandemic reshaped public attitudes toward self-care and diagnostics. Nathan Patton, vice president of near patient care marketing, shares how expanded testing access and collaboration are shaping future public health efforts.

2024

CAP Today

May 3, 2024

Digital pathology mini-roundtable

Is digital pathology on the move? Two who know it well say it is. Esther Abels, a precision medicine and biomedical regulatory health science expert who is CEO of SolarisRTC and former president of the Digital Pathology Association, and Michael Rivers, vice president/lifecycle leader of digital pathology at Roche Tissue Diagnostics, spoke in September with CAP TODAY publisher Bob McGonnagle, who got their take on where things stand.

Medical Laboratory Observer

April 22, 2024

2024 lab management best practices trend back to the basics

The results of the 2024 Medical Laboratory Observer (MLO) State of the Industry (SOI) Survey on Lab Management Best Practices reveal how many lab professionals are turning to fundamental practices and priorities to make operational, clinical and financial improvements – from a focus on staff career development to strengthening supplier relationships.

MedTech Dive

April 12, 2024

Roche scores FDA breakthrough status for Alzheimer’s blood test

Roche has received the Food and Drug Administration’s breakthrough device designation for a blood test to support earlier diagnosis of Alzheimer’s disease, the Swiss drug and diagnostics company said Thursday. The test, once approved, could help healthcare providers identify whether amyloid pathology, a marker for Alzheimer’s disease, is present or absent in patients. The Elecsys pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly.

Contemporary OBGYN

April 3, 2024

Enhancing cervical cancer management with dual stain

In a video interview, Carolyn Kay, MD, discusses the latest ASCCP guidelines and the introduction of dual stain cytology for improved HPV detection and patient management, aiming to alleviate anxiety and enhance efficacy in cervical cancer prevention.

2023

Medical Laboratory Observer

November 20, 2023

Actionable answers: Targeted multiplex PCR respiratory testing at the point of care

In the unpredictable post-COVID-19 pandemic era, patient expectations have shifted when it comes to diagnostic testing.

CLP

November 16, 2023

16 clinical laboratory predictions for 2024

Consolidation, legislation, new testing modalities, and a shift to more consumer-driven testing are just some of the clinical laboratory predictions for 2024.

Medscape

November 15, 2023

Blood test for MS activity gets FDA breakthrough designation

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS). Made by Roche, the test is intended to be used as an aid in detection of disease activity in adults aged 18-55 years with relapsing-remitting multiple sclerosis (RRMS) or secondary progressive multiple sclerosis (SPMS), providing insights for disease management.

CLP

October 17, 2023

Roche launches automated vertical transportation for patient lab samples

Roche has launched a laboratory conveyor system, the cobas connection modules (CCM) Vertical, for the U.S. market. The elevator and overhead components of its fully automated and modular CCM system are designed to help low-, mid-, and high-volume laboratories optimize space, productivity, and patient care.

NeurologyLive

June 27, 2023

FDA clears Roche’s Beta-Amyloid and Total-Tau assays for Alzheimer assessment

With the approval, Roche has three FDA-cleared tests that are reflective of the main Alzheimer's disease pathologies and help clinicians more completely define the disease biologically.

Medical Laboratory Observer

January 23, 2023

Shifting HIV focus from at-risk populations to at-risk behavior

Since 2015, only about 1.2 million people have been considered ‘at risk’ of HIV and potentially able to benefit from pre-exposure prophylaxis, also known as PrEP, according to medical literature. These numbers were gleaned by focusing on identifiable populations, such as men who have sex with men and drug users who use needles.

2022

Medical Laboratory Observer

September 21, 2022

Breast cancer biomarkers, and a new clinical category for HER2 expression

Recent advances in treating breast cancer are reaching back to the past to the first known biomarker, human epidermal growth factor, to determine its value in treating patients with lower levels of HER2 expression and potentially open the door to new, targeted, and personalized therapies for many patients.

Medical Laboratory Observer

August 24, 2022

Navigating respiratory disease testing challenges this fall

If respiratory diseases were not complicated enough before COVID-19, this fall may be the example of peak complexity as atypical infectious disease seasons threaten to become the new normal and COVID-19 continues to mutate.

Latest news

...

User profile

Select your user profile

Roche in the news

Catch up on the latest news, innovation and thought leadership from Roche Diagnostics.

Select Science - September 1, 2026

How automated mass spectrometry is expanding clinical lab capacity

Select Science - August 18, 2026

Automated LC-MS/MS brings clinical mass spectrometry closer to routine testing

Today's Clinical Lab - July 16, 2026

Blood-Based Biomarkers Are Transforming the Diagnosis of Alzheimer’s Disease

The Analytical Scientist - July 3, 2026

A Turning Point for Clinical Mass Spec?

Lab Manager - June 19, 2026

Building Resilient Clinical Labs Amidst Workforce Shortages

Today's Clinical Lab - April 28, 2026

‘Moderate Complexity’ Mass Spectrometry Arrives in Clinical Labs

Past Coverage

2025

Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend

FDA clears blood test to help rule out Alzheimer’s disease in people showing symptoms

Pathology labs are redefining ROI for digital pathology

Why One Pathologist Calls for a ‘Patient Behind Every Sample’ Mindset

Two Imperatives for the Future of Diagnostics: Adaptability and Digitalization to Unlock the Potential of AI

Should labs add Lp(a) testing to their menus?

Roche Digital Pathology Dx whole slide imaging system is comparable to traditional microscopy for primary diagnosis in surgical pathology

Streamlining patient pathways in Alzheimer's disease with emerging biomarkers

COVID next: Charting an evolving industry

The COVID-19 pandemic: Five years on

The COVID-19 pandemic: Significance of screening and industry's response

2024

Digital pathology mini-roundtable

2024 lab management best practices trend back to the basics

Roche scores FDA breakthrough status for Alzheimer’s blood test

Enhancing cervical cancer management with dual stain

2023

Actionable answers: Targeted multiplex PCR respiratory testing at the point of care

16 clinical laboratory predictions for 2024

Blood test for MS activity gets FDA breakthrough designation

Roche launches automated vertical transportation for patient lab samples

FDA clears Roche’s Beta-Amyloid and Total-Tau assays for Alzheimer assessment

Shifting HIV focus from at-risk populations to at-risk behavior

2022

Breast cancer biomarkers, and a new clinical category for HER2 expression

Navigating respiratory disease testing challenges this fall

Latest news